These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38520017)

  • 81. Empirical assessment of wounds among people who use substances.
    Jones JD; Chaple M; Rozen S; DelaCuesta C; Sosa ES; Bryant K
    Drug Alcohol Depend; 2024 Sep; 262():111375. PubMed ID: 38971028
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Opportunities to improve inpatient services and reduce rates of patient-direct discharge among people who use substances.
    Peters H; Liaukovich A; Grace N; Ausman C; Kiepek N
    Hosp Pract (1995); 2024 Aug; 52(3):64-76. PubMed ID: 39081137
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.
    Brown SJ; Carter GJ; Halliwell G; Brown K; Caswell R; Howarth E; Feder G; O'Doherty L
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013648. PubMed ID: 36194890
    [TBL] [Abstract][Full Text] [Related]  

  • 84. What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada.
    Mathias H; Jackson LA; Buxton JA; Dubé A; Kiepek N; Martin F; Martin P
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):20. PubMed ID: 38520017
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.
    Marshall T; Viste D; Jones S; Kim J; Lee A; Jafri F; Krieg O; Ghosh SM
    Harm Reduct J; 2023 Jun; 20(1):80. PubMed ID: 37355610
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Emergency department care experiences among people who use substances: a qualitative study.
    Rajab D; Fujioka JK; Walker M; Bartels SA; MacKenzie M; Purkey E
    Int J Equity Health; 2023 Dec; 22(1):248. PubMed ID: 38049838
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Safety and danger: Perceptions of the implementation of harm reduction programs in two communities in Nova Scotia, Canada.
    Jackson LA; Dechman M; Mathias H; Gahagan J; Morrison K
    Health Soc Care Community; 2022 Jan; 30(1):360-371. PubMed ID: 34060676
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Exploring the experiences of adults with stroke in virtual community-based stroke programs: a qualitative descriptive study.
    Cruickshank A; Brooks ED; Sperling C; Nelson M; Singh H
    BMC Health Serv Res; 2024 May; 24(1):600. PubMed ID: 38715062
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An environmental scan of residential treatment service provision in Ontario.
    Ali F; Law J; Russell C; Bozinoff N; Rush B
    Subst Abuse Treat Prev Policy; 2023 Dec; 18(1):73. PubMed ID: 38087331
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in west Virginia.
    Winiker AK; Schneider KE; Hamilton White R; O'Rourke A; Grieb SM; Allen ST
    Harm Reduct J; 2023 Jun; 20(1):69. PubMed ID: 37264367
    [TBL] [Abstract][Full Text] [Related]  

  • 91. British Columbia trials drug decriminalization.
    Duong D
    CMAJ; 2023 Feb; 195(7):E281. PubMed ID: 36810222
    [No Abstract]   [Full Text] [Related]  

  • 92. Predictors of barriers to accessing youth mental health and/or addiction care.
    Chan S; Markoulakis R; Levitt A
    J Can Acad Child Adolesc Psychiatry; 2023 Feb; 32(1):27-37. PubMed ID: 36776928
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study.
    Poulsen MN; Asdell PB; Berrettini W; McBryan K; Rahm AK
    SSM Ment Health; 2022 Dec; 2():. PubMed ID: 36776723
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.
    Pijl EM; Alraja A; Duff E; Cooke C; Dash S; Nayak N; Lamoureux J; Poulin G; Knight E; Fry B
    Subst Abuse Treat Prev Policy; 2022 Aug; 17(1):62. PubMed ID: 36028837
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A rural community's perspective on the causes of and solutions to the opioid crisis in southern Virginia: a qualitative study.
    Hargrove AJ; Rafie C; Zimmerman E; Moser DE
    Rural Remote Health; 2022 Jun; 22(2):7152. PubMed ID: 35641244
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.